Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic dermatitis: A retrospective study
Pediatric Dermatology · 2024
DOI: 10.1111/pde.15704 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Dermatology, 2024. Verfasst von Cheryl J Hartzell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pain Management Center, Cincinnati Children's Hospital, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Aprepitant, Pruritus, Dermatitis, Atopic, Epidermolysis Bullosa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Introduction
At a single‐center pediatric hospital, the neurokinin‐1 receptor antagonist aprepitant was used to treat refractory pruritus in epidermolysis bullosa (EB) and atopic dermatitis (AD).
Methods
Thirty‐seven patients were included (24 EB patients, 13 AD patients), ages 10 months to 37 years.
Results
58% (14/24) of patients with EB and 85% (11/13) of patients with AD reported aprepitant was effective in decreasing their pruritus, with age‐related differences in efficacy observed in EB patients, and access to the medication by insurance denial or availability of the drug as a barrier to use.
Conclusions
Aprepitant shows promise in controlling refractory pruritus in pediatric EB and AD patients and deserves further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pain Management Center, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
ORCID-Profile: Cheryl J Hartzell
Zitieren
APA
Hartzell, C. J., Szabova, A., Collins, A. B., Morel, A. N., Mijatovic, D., & Goldschneider, K. R. (2024). Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic dermatitis: A retrospective study. Pediatric Dermatology. https://doi.org/10.1111/pde.15704
Vancouver
Hartzell CJ, Szabova A, Collins AB, Morel AN, Mijatovic D, Goldschneider KR. Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic dermatitis: A retrospective study. Pediatric Dermatology. 2024. doi:10.1111/pde.15704
BibTeX
@article{Hartzell2024,
author = {Hartzell, Cheryl J and Szabova, Alexandra and Collins, Andrew B and Morel, Armand N and Mijatovic, Desimir and Goldschneider, Kenneth R},
title = {Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic dermatitis: A retrospective study},
journal = {Pediatric Dermatology},
year = {2024},
doi = {10.1111/pde.15704}
}
EUVIMED